• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/26

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

26 Cards in this Set

  • Front
  • Back
3 pathways to pathogenesis as a result of a defective metabolic enzyme
loss of product

accumulation of substrate

alternate pathway (diversion of substrate into a different pathway producing toxic effects)
glactosemia
autosomal recessive

mutation in Gal-1-P uridyl transferase

mutation of Gal-1P is toxic to liver and kidney

conversion of built up galactose to galactitol is toxic to lungs and causes cateracts
galactitol
in galactosemia, build up of galactose gets converted to galacititol which is toxic to lung and causes cateracts
Gal-1-phosphate
builds up in galacosemia, toxic to liver and kidney
galactosemia clinical
vomiting, diarrhea, hypoglycemia, acidosis, failure to thrive, jaundice, hepatomegaly, cateracts, hemolysis, mental retardation, ecoli sepsis
galactosemia diagnosis
screen for negative urine glucose oxidase

confirm with direct measurement of gal-1 PUT enzyme activity
galactosemia treatment
eliminate galactose/lactose in diet

dietary restriction in heterozygote mother during pregnancy

calcium suppliment
tyrosinemia pathogenesis
auto rec

defect in fumyrlacetoacetate hydrolase (FAH)

accumulation of maleylacetoacetate and fumarylacetoacetate = combine to succinylacetone

succinylacetone blocks conversion of delta-ALA (aminolevunic acid) to prophobilinogen

damage to liver, kidney, brain
tyrosinemia clinical
hepatic - liver damage, cholestasis, cirrhosis, hepatocellular carcinoma

renal - tubular dysfunction: rickets, + others

neurological crisis - parethesis, hypertension, teachcardia, progressive weakness -> paralysis, death
tyrosinemia diagnosis
suspect in patients with liver issues + rickets, coagulopathy, neurological crisis

increase urine and blood succinylacetone

decreased FAH in blood

plasma tyrosine level USELESS
tyrosinemia treatment
dietary restruction of phenylalanine and trosine

NTBC

liver transplant
hemochromatosis
excessive accumulation of iron, which deposits everywhere

hereditary or acquired

hereditary form due to HFE gene on chromosome 6
hereditary hemochomatosis
HFE gene mutation on chr 6
most common mutation is C282Y
more common in males

overexpression of divalent metal iron transporter (DMT) -> too much absorption of iron - slow accumulation
hemochromatosis clinical
bronzing of skin

diabetes from pancreas damage

liver cancer from liver damage
hemochromatosis diagnosis
increased serum iron, ferritin, TIBC

liver biopsy - hepatic iron >5600ug/g
ferritin level and serum iron in hemochromatosis
both ferritin and serum iron increased
ferritin level and serum iron in acute infection
ferrtin increased, serum iron low
ferritin level and serum iron in anemia of chronic disease
ferritin is normal, decreased serum iron
ferritin level and serum iron in anemia
ferritin decreased, serum iron decreased
treatment of hemochromatosis
phlebotomy
wilson's disease pathogenesis
auto rec

mutation in ATP7B on chr 13

unable to excrete copper into bile - accumulation of Cu

unable to make ceruloplasmin with copper - decrease

Cu build up damages liver, basal ganglia, cornea, kidney, other tissues
in the blood, copper is carried by
albumin to the liver
fate of copper in the body
incorporated to alpha2 globulin to form ceruloplasmin
wilson's disease clinical
kaiser fleischer rings, neuropsych disorider, cadiomyopathy, hepatitis, cirrhosis, fanconi syndrome, HEMOLYTIC ANEMIA, osteopenia
alpha1 anti-trypsin deficiency
auto rec

chr14

deficiency of protease inhibitor

lung disease caused by inhibited action of proteinases

liver disease caused by intracellular accumulation of defective alpha1AT

increased risk of hepatocellular carcinoma
alpha1 antitrypsin deficiency diagnosis
increased LFT

increased GGT

A1AT level

liver biopsy - giant cell hepatitis, cirrhosis, red hyaline globule on stain